Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Health In Tech Inc (HIT)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
$0.58-3.53%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for HIT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
manage ongoing litigation and regulatory issues | A supporting condition in Health In Tech Inc's published investment case. The stated target is no new material negative litigation events. | Under Pressure | new material negative litigation or regulatory event occurs | 3 new litigation events vs 0 target Multiple 8-K filings report new litigation and a Nasdaq delisting notice, confirming the occurrence of new material negative regulatory and legal events. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk turnaround-style business, not a proven durable compounder. The thesis is in a watch state, with medium confidence, and recent financial performance is below its industry cohort.
HIT screens cheap versus peers, but its valuation model has low confidence and the expectations gap is negative. That suggests the low relative valuation does not yet establish that the market has priced in a recovery; the evidence snapshot gives no basis to be more certain.
Near term, management has reaffirmed guidance, expanded distribution partners, upgraded platform architecture, and secured the first employer group under its rate stabilization program. These are concrete steps, but Q2 revenue declined year over year, and the snapshot describes earnings as loss-making. A CEO transition, delisting notice, and litigation add near-term execution and business risks.
The multi-year thesis hinges on whether partner growth, platform work, and the new program lead to a better revenue trajectory. A guidance cut would be a meaningful negative; rate cuts or stabilization among major technology companies could support the sector backdrop, but neither resolves HIT’s company-specific execution risks.
Over the next 1 to 3 years, HIT’s thesis depends on turning operational milestones into improved financial results while managing leadership and legal uncertainty. Current evidence shows progress in initiatives, but not yet in revenue, and confidence has weakened. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
improve operating income from negative levels |
| A primary condition in Health In Tech Inc's published investment case. The stated target is operating income improves above -$2.1 million. |
| Broken |
| operating income stays below -$2.1 million over next year |
Operating income: $-3.438M FY2026-Q2; GAAP. Published target: operating income improves above -$2.1 million. Target period is not explicitly aligned with this observation. Aug 13, 2026-3,438,301 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
2026 revenue between $45M and $50M | A primary condition in Health In Tech Inc's published investment case. The stated target is >= $45 million and <= $50 million. | Intact | revenue falls below $45 million in FY26 | Revenue: $8.057M FY2026-Q2; GAAP. Published target: >= $45 million and <= $50 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 20268,056,620 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.17 → $-0.00 · observed estimates
$0.08B → $0.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-07-25 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-07-26 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-07-27 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-07-28 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-07-29 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-07-30 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-07-31 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-01 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-02 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-03 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-04 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-05 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-06 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-07 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-08 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-09 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-10 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-12 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-13 | $0.14 | $78,524,300 | 3 / 3 |
| 2026-08-14 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-15 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-16 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-17 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-18 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-19 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-20 | $0.17 | $78,769,000 | 2 / 2 |
| 2026-08-21 | $0.03 | $67,800,000 | 2 / 2 |
| 2026-08-22 | $0.03 | $67,800,000 | 2 / 2 |
| 2026-08-23 | $0.03 | $67,800,000 | 2 / 2 |
| 2026-08-24 | $0.03 | $67,800,000 | 2 / 2 |
| 2026-08-25 | $0.03 | $67,800,000 | 2 / 2 |
| 2026-08-26 | $0.03 | $67,800,000 | 2 / 2 |
| 2026-08-27 | $0.03 | $67,800,000 | 2 / 2 |
| 2026-08-28 | $0.03 | $67,800,000 | 2 / 2 |
| 2026-08-29 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-08-30 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-08-31 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-01 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-02 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-03 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-04 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-05 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-06 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-07 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-08 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-09 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-10 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-11 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-12 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-13 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-14 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-15 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-16 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-17 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-18 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-19 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-20 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-21 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-22 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-23 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-24 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-25 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-26 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-27 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-28 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-29 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-09-30 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-10-01 | $0.05 | $71,200,000 | 2 / 2 |
| 2026-10-02 | $0.04 | $66,263,667 | 2 / 2 |
| 2026-10-03 | $0.04 | $54,115,667 | 1 / 2 |
| 2026-10-04 | $0.04 | $54,115,667 | 2 / 2 |
| 2026-10-05 | $0.04 | $54,115,667 | 2 / 2 |
| 2026-10-06 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-07 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-08 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-09 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-10 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-11 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-12 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-13 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-14 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-15 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-16 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-17 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-18 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-19 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-20 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-21 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-22 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-23 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-24 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-25 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-26 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-27 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-28 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-29 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-30 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-10-31 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-11-01 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-11-02 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-11-03 | $-0.00 | $54,130,333 | 2 / 2 |
| 2026-11-04 | $-0.00 | $54,130,333 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.